Investing in Tomorrow's Health

NCL Technology Ventures invests transformational equity capital in entrepreneurs who have truly innovative technologies.

Our Investment Strategy

We invest in Seed and Series A rounds where we can deploy our expertise and capital to help our companies achieve an early inflection point in valuation. We consciously choose investments that create an impact on the lives of patients as well as financial return for our investors.

Our Value Add:

We provide a package of human and capital resources over the life of our investments including:

  • – Strong scientific knowledge and frontline healthcare experience
  • – Developmental and leadership building experience
  • – A carefully built local and global network of healthcare specialists
  • – An overriding ambition to succeed in bringing new innovation in healthcare to benefit global recipients

 We are pleased with the performance of Fund 1 and have therefore decided to back Fund 2 as a cornerstone investor.”

– Health Technology Fund II LP

Our Portfolio

Our investments keep making strides in their fields and winning awards in recognition.

All Digital Health Medical Technologies Therapeutics
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo

NCLs Health Technology Fund II

NCL has recently launched it Health Technology Fund II.  The fund has been designed to take positions in pioneering new technologies that can create significant patient impact and produce upper quartile investment returns.

The fund has launched in partnership with several leading UK institutions including Kings College, NHS and our delivery partner Catalent Inc (NYSE: CLT). Documentation can be provided to professional investors only upon request.

Whether a potential investor or an entrepreneur we invite you to discuss your goals and ambitions with us.

Our Team

Our team spans three generations and is vastly experienced in venture investment, fund structuring, entrepreneurship and business management and is supported by an expert Scientific Advisory Board.

All Board of Directors International Investment Team Scientific Advisory Board Support Team
Jerry Biggs's headshot

Jerry Biggs

CEO
View Profile
Emma Sugrue's headshot

Emma Sugrue

Executive Assistant
View Profile
Jonathan Synett's headshot

Jonathan Synett

CIO
View Profile
Pat O’Neill's headshot

Pat O’Neill

President - US Operations
View Profile
Graham Hutchins's headshot

Graham Hutchins

Operations Director
View Profile
Chris Phillips's headshot

Chris Phillips

Executive Advisor
View Profile
Jon Scott-Maxwell's headshot

Jon Scott-Maxwell

Non-Executive Director
View Profile
Professor Clive Page's headshot

Professor Clive Page

View Profile
Professor Michelle Garrett's headshot

Professor Michelle Garrett

View Profile
Martin Riley's headshot

Martin Riley

View Profile
Julien Meissonnier's headshot

Julien Meissonnier

View Profile
Professor John Wood CBE FREng's headshot

Professor John Wood CBE FREng

View Profile
Graeme Cox's headshot

Graeme Cox

View Profile

Our News

Sana Health Receives FDA “Breakthrough Device Designation” for Sana Device as At-Home aid for Fibromyalgia

LAFAYETTE, CO Sana Health ( http:///www.sana.io ) , a Colorado-based medical technology startup backed by global hard tech investor firm SOSV and Founders Fund, … Continued

Read more

Ampersand Health launches a new digital therapeutic for people living with Inflammatory Arthritis

19th January 2021, London: Ampersand Health, experts in digital therapeutics for long-term inflammatory conditions, announce the launch of My Arthritis DTx to support people living with … Continued

Read more

Research by emteq labs reveals how emotion measurement could redefine treatment for anxiety, depression and PTSD

The AI Journal has covered the latest research by portfolio Emteq, acknowledging their current success milestones and the implications of their research for emotion … Continued

Read more

Attracting Venture Capital

NCL Technology Ventures are delivering a 12-hour programme for aspiring Chief Executive’s and Chief Technology Officers on how to attract venture capital investment for their businesses.

The programme will be delivered on behalf of the South-East Innovation Programme (SE-IP) and provide early-stage entrepreneurs and companies with an overview of the fund-raising process from the point of view of a Venture Capitalist, including a checklist of requirements for an entrepreneur to complete when fund-raising and an opportunity to review their business plan/pitch-deck.

The programme is run over 2 days and takes 12 hours. It is open to entrepreneurs and businesses based in the South East Local Enterprise Partnership area (Essex, South-End, Grays, Kent and East Sussex).

If you are interested in participating contact us at seip@ncltv.co.uk .

The programme is being run on behalf of Maidstone Borough Council.

Learn more

 

Want to discuss an investment opportunity with us?

Submit an Opportunity